Lancet Oncology Archives

Study Details Which Cancer Patients are Most Susceptible to Severe Effects from Covid-19

Analysis, Breast Cancer, Cancer, Coronavirus Disease 2019 (COVID-19), Data, Demographics, Hematologic malignancies, Lancet Oncology, Leukemia, Oxford University, Prostate Cancer, R&D, Studies, Tumors, United Kingdom

Research published in Lancet Oncology analyzed how the risk of death from Covid-19 varies by tumor subtype and patient demographics.

September 1, 2020/by Andrew Humphreys

Eli Lilly’s Cyramza Passes FDA Advisory Hurdle for NSCLC

EGFR Mutations, Lancet Oncology, Non-Small Cell Lung Cancer (NSCLC), Oncologic Drugs Advisory Committee (ODAC), Untreated Metastatic EGFR-Positive Non-Small Cell Lung Cancer (NSCLC)

Indianapolis-based Eli Lilly announced the FDA’s Oncologic Drugs Advisory Committee voted 6-5 in favor of Cyramza (ramucirumab) plus erlotinib as a potential treatment for patients with untreated metastatic EGFR-positive non-small cell lung cancer (NSCLC).

February 27, 2020/by BioSpace